XML 71 R56.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Segment Information (Details)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2016
USD ($)
Oct. 01, 2016
USD ($)
Jul. 02, 2016
USD ($)
Apr. 02, 2016
USD ($)
Dec. 31, 2015
USD ($)
Sep. 26, 2015
USD ($)
Jun. 27, 2015
USD ($)
Mar. 28, 2015
USD ($)
Dec. 31, 2016
USD ($)
Segment
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Segment Reporting Information [Line Items]                      
Number of Reportable Segments | Segment                 4    
Revenues $ 4,953.2 $ 4,490.9 $ 4,535.2 $ 4,294.8 $ 4,652.5 $ 4,123.2 $ 4,270.9 $ 3,918.8 $ 18,274.1 $ 16,965.4 $ 16,889.6
Cost of revenues charges                 (101.5) (9.1) (327.6)
Selling, general and administrative charges, net                 (103.9) (46.3) (130.7)
Restructuring and other (costs) income, net                 (189.2) (115.3) 598.2
Amortization of acquisition-related intangible assets                 (1,380.0) (1,310.0) (1,330.0)
Operating Income                 2,449.2 2,336.2 2,503.0
Other expense, net                 (425.3) (399.8) (415.8)
Income from Continuing Operations Before Income Taxes                 2,023.9 1,936.4 2,087.2
Depreciation                 380.0 373.4 353.1
Total Assets 45,907.5       40,834.3       45,907.5 40,834.3 42,852.1
Capital Expenditures                 444.4 422.9 427.6
Life Sciences Solutions [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (31.2) (2.0) (327.3)
Selling, general and administrative charges, net                 (36.0) (13.6) (122.5)
Restructuring and other (costs) income, net                 (87.6) (64.4) 516.4
Total Assets 18,454.3       17,884.3       18,454.3 17,884.3 19,257.0
Capital Expenditures                 116.7 85.1 104.4
Analytical Instruments [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (62.4) (0.1) 0.8
Selling, general and administrative charges, net                 (46.5) 0.3 (0.9)
Restructuring and other (costs) income, net                 (68.3) (26.6) (2.5)
Total Assets 9,519.6       4,763.1       9,519.6 4,763.1 4,133.3
Capital Expenditures                 34.0 59.5 38.1
Specialty Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                   (0.8) (0.9)
Selling, general and administrative charges, net                 0.3 0.4 (1.5)
Restructuring and other (costs) income, net                 (14.9) (9.7) (17.7)
Total Assets 6,801.6       7,183.2       6,801.6 7,183.2 8,047.7
Capital Expenditures                 72.3 75.9 84.7
Laboratory Products and Services [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (7.9) (6.2) (0.2)
Selling, general and administrative charges, net                 (0.5) (6.1)  
Restructuring and other (costs) income, net                 (17.7) (12.6) 121.0
Total Assets 10,016.3       10,266.6       10,016.3 10,266.6 10,875.7
Capital Expenditures                 116.8 97.7 102.1
Corporate and Other [Member]                      
Segment Reporting Information [Line Items]                      
Total Assets [1] $ 1,115.7       $ 737.1       1,115.7 737.1 538.4
Capital Expenditures                 104.6 104.7 98.3
Total Reportable Segments [Member]                      
Segment Reporting Information [Line Items]                      
Operating Income                 4,221.8 3,821.7 3,694.8 [2]
Total Reportable Segments [Member] | Life Sciences Solutions [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 4,978.1 4,439.4 4,195.7
Operating Income                 1,514.7 1,336.9 1,214.9 [2]
Depreciation                 141.4 146.3 131.6
Total Reportable Segments [Member] | Analytical Instruments [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 3,668.2 3,208.2 3,252.2
Operating Income                 745.2 612.8 581.1 [2]
Depreciation                 49.7 38.9 39.0
Total Reportable Segments [Member] | Specialty Diagnostics [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 3,339.2 3,243.9 3,343.6
Operating Income                 909.8 872.9 916.0 [2]
Depreciation                 70.4 73.7 76.7
Total Reportable Segments [Member] | Laboratory Products and Services [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 7,030.0 6,661.5 6,601.5
Operating Income                 1,052.1 999.1 982.8 [2]
Depreciation                 118.5 114.5 105.8
Intersegment Eliminations [Member]                      
Segment Reporting Information [Line Items]                      
Revenues                 (741.4) (587.6) (503.4)
Segment Reconciling Items [Member]                      
Segment Reporting Information [Line Items]                      
Cost of revenues charges                 (101.5) (9.1) (327.6)
Selling, general and administrative charges, net                 (103.9) (46.3) (130.7)
Restructuring and other (costs) income, net                 (189.2) (115.3) 598.2
Amortization of acquisition-related intangible assets                 $ (1,378.0) $ (1,314.8) $ (1,331.7)
[1] Corporate assets consist primarily of cash and cash equivalents, short-term investments, property and equipment at the company's corporate offices.
[2] Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.